Wave Life Sciences
Dec 17, 2019
Wave Life Sciences stocks implode; Amarin’s VASCEPA approval; GSK seeks approval
Wave Life Sciences has recently announced the discontinuation of its drug suvodirsen, for the treatment of a rare Duchenne Muscular Dystrophy mutation. Duchenne Muscular Dystrophy is a progressive worsening of the skeletal and heart muscles resulting in weakness. The disorder, is due to deficient prot...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
